Viewing Study NCT02488512

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:46 PM
Ignite Modification Date: 2026-02-03 @ 9:35 AM
Study NCT ID: NCT02488512
Status: TERMINATED
Last Update Posted: 2018-03-19
First Post: 2015-06-19
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Peptide Receptor Radionuclide Therapy With 90Y-Dotatoc in Relapsed/Refractory Diffuse Large B Cell and Mantle Cell Lymphomas
Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None DLBCL View
None MCL View
None Recurrent Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Relapsed/refractory diffuse large b cell View
None Relapsed/refractory mantle cell lymphomas View
None DLBCL View
None MCL View
None 90Y-DOTATOC View
None SSR-positive tumour View